Related Experiment Video
Updated: Jul 26, 2026

08:16
Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
Published on: November 5, 2016
8.1K
"Advancing cardiac patch viability and functionality: innovations in scaffold design and cellular optimization"
Ahmed Eliwa1, M K G Abbas2, Maryam Al-Ejji2
1Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar. ae1801741@qu.edu.qa.
Journal of Materials Science. Materials in Medicine
|October 11, 2025
Summary
Cardiac patches offer new hope for heart disease treatment by supporting and regenerating damaged tissue. Innovations in materials, cell sources, and culture methods are key to their clinical success and long-term functionality.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiac patches are engineered tissues designed to repair heart damage after myocardial infarction (MI).
- They provide structural support and promote cardiac tissue regeneration by mimicking a functional, contractile environment.
- Challenges remain in ensuring cell viability and functionality for large-scale cardiac patch production and clinical application.
Purpose of the Study:
- To review strategies for enhancing the effectiveness of cardiac patches in treating heart disease.
- To address the critical challenge of maintaining cell viability and functionality during large-scale patch production.
- To explore innovative methods for advancing cardiac patch technology for clinical use.
Main Methods:
- Incorporation of conductive and biocompatible scaffold materials to mimic native cardiac tissue.
- Strategies for promoting vascularization and optimizing cell sources and culture conditions.
- Utilizing controlled release systems for growth factors, surface modification, and mechanical conditioning during in vitro culture.
Main Results:
- The review highlights various techniques crucial for successful cardiac patch fabrication.
- Effective strategies involve material selection, cell optimization, and controlled delivery systems.
- These methods aim to improve cell survival, tissue integration, and overall patch performance.
Conclusions:
- Advancing cardiac patch technology requires a multidisciplinary approach integrating materials science, cell biology, and engineering.
- Optimizing patch design and fabrication is essential for successful clinical translation in treating heart disease.
- Continued innovation in cardiac patch development holds significant promise for cardiovascular regenerative medicine.
Related Concept Videos
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

